Antitumour metal compounds: more than theme and variations
Top Cited Papers
- 7 November 2007
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- No. 2,p. 183-194
- https://doi.org/10.1039/b712656p
Abstract
Triggered by the resounding success of cisplatin, the past decades have seen tremendous efforts to produce clinically beneficial analogues. The recent achievement of oxaliplatin for the treatment of colon cancer should, however, not belie the imbalance between a plethora of investigated complexes and a very small number of clinically approved platinum drugs. Strategies opening up new avenues are increasingly being sought using complexes of metals other than platinum such as ruthenium or gallium. Based on the chemical differences between these metals, the spectrum of molecular mechanisms of action and potential indications can be broadened substantially. Other approaches focus on complexes with tumour-targeting properties, thereby maximizing the impact on cancer cells and minimizing the problem of adverse side effects, and complexes with biologically active ligands.Keywords
This publication has 116 references indexed in Scilit:
- Synthesis andin vitroAntitumor Potency of (Cyclohexane-1,2-Diamine)Platinum(II) Complexes with Aminotris(Methylenephosphonic Acid) as Bone-Seeking LigandBioinorganic Chemistry and Applications, 2005
- Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cellsZeitschrift für Krebsforschung und Klinische Onkologie, 2004
- Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinomaEuropean Journal Of Cancer, 2004
- Platinum complexes with imino ethers or cyclic ligands mimicking imino ethers: synthesis, in vitro antitumour activity, and DNA interaction propertiesJBIC Journal of Biological Inorganic Chemistry, 2004
- Actin-dependent tumour cell adhesion after short-term exposure to the antimetastasis ruthenium complex NAMI-AEuropean Journal Of Cancer, 2004
- Phase II trial of BBR3464, a novel, bifunctional platinum analog, in advanced but favorable out-come, Non Small Cell Lung Cancer patientsEuropean Journal Of Cancer, 2001
- Phase II clinical study of BBR 3464, a novel, bifunctional platinum analogue, in patients with advanced ovarian cancerEuropean Journal Of Cancer, 2001
- Chemistry and Pharmacokinetics of Gallium Maltolate, a Compound With High Oral Gallium BioavailabilityMetal-Based Drugs, 2000
- Preclinical activity of trans-indazolium [tetrachlorobisindazoleruthenate(III)] (NSC 666158; IndCR; KP 1019) against tumour colony-forming units and haematopoietic progenitor cellsEuropean Journal Of Cancer, 1997
- Binding of ruthenium(III) anti-tumor drugs to human lactoferrin probed by high resolution X-ray crystallographic structure analysesJBIC Journal of Biological Inorganic Chemistry, 1996